Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Inc

215.71
+0.92000.43%
Post-market: 215.710.00000.00%19:25 EDT
Volume:710.53K
Turnover:153.56M
Market Cap:25.84B
PE:50.77
High:217.20
Open:215.68
Low:214.80
Close:214.79
Loading ...

PTC and Schaeffler Expand Strategic Relationship with Adoption of Windchill+ PLM

PR Newswire
·
30 Apr

PTC Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
30 Apr

PTC Gearing Up to Report Q2 Earnings: Here's What to Expect

Zacks
·
28 Apr

Barclays Remains a Buy on PTC (PTC)

TIPRANKS
·
28 Apr

1 S&P 500 Stock on Our Buy List and 2 to Question

StockStory
·
28 Apr

PTC India Limited Announces New Leadership and Dividend

TIPRANKS
·
26 Apr

PTC Therapeutics Says Potential Phenylketonuria Drug Receives EU Panel's Positive Opinion

MT Newswires Live
·
25 Apr

PTC Therapeutics Receives Positive CHMP Opinion for Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)

PR Newswire
·
25 Apr

PTC Therapeutics CEO Makes Significant Stock Move

TIPRANKS
·
25 Apr

PTC Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
24 Apr

PTC Inc. (PTC) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
23 Apr

PTC India Board to Consider Interim Dividend for Fiscal 2025

MT Newswires Live
·
23 Apr

PTC Therapeutics Price Target Maintained With a $65.00/Share by RBC Capital

Dow Jones
·
22 Apr

Baird Adjusts Price Target on PTC to $185 From $181, Maintains Outperform Rating

MT Newswires Live
·
22 Apr

PTC Is Maintained at Outperform by Baird

Dow Jones
·
22 Apr

PTC Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
22 Apr

PTC Therapeutics (PTCT) Earnings Expected to Grow: Should You Buy?

Zacks
·
17 Apr

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2025 Financial Results

PR Newswire
·
17 Apr

PTC Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
17 Apr

PTC price target lowered to $183 from $220 at BMO Capital

TIPRANKS
·
16 Apr